Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 1713290 | 9.994E-5 | CS |
4 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 314404 | 9.903E-5 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0004 | 1.0E-6 | 150853 | 9.464E-5 | CS |
26 | -0.000199 | -99.5 | 0.0002 | 0.0405 | 1.0E-6 | 78527 | 0.00011392 | CS |
52 | -0.000299 | -99.6666666667 | 0.0003 | 0.0405 | 1.0E-6 | 99299 | 0.00036158 | CS |
156 | -0.509999 | -99.9998039216 | 0.51 | 0.66 | 1.0E-6 | 636493 | 0.03140433 | CS |
260 | -0.387499 | -99.9997419355 | 0.3875 | 3.75 | 1.0E-6 | 395886 | 0.21447403 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約